Title : Neoadjuvant administration of hydroxychloroquine in a phase 1 clinical trial induced plasma Par-4 levels and apoptosis in diverse tumors.

Pub. Date : 2018 May

PMID : 30603055






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Neoadjuvant administration of hydroxychloroquine in a phase 1 clinical trial induced plasma Par-4 levels and apoptosis in diverse tumors. Hydroxychloroquine Prader Willi/Angelman region RNA 4 Homo sapiens
2 Chloroquine and hydroxychloroquine (HCQ) are robust inducers of the tumor suppressor Par-4 secretion from normal cells. Hydroxychloroquine Prader Willi/Angelman region RNA 4 Homo sapiens
3 Chloroquine and hydroxychloroquine (HCQ) are robust inducers of the tumor suppressor Par-4 secretion from normal cells. Hydroxychloroquine Prader Willi/Angelman region RNA 4 Homo sapiens
4 Eight of the nine patients treated with HCQ showed elevation in plasma Par-4 levels over basal levels. Hydroxychloroquine Prader Willi/Angelman region RNA 4 Homo sapiens
5 The resected tumors from the eight HCQ-treated patients with elevated plasma Par-4 levels, but not the resected tumor from the patient who failed to induce plasma Par-4 levels, exhibited TUNEL-positivity indicative of apoptosis. Hydroxychloroquine Prader Willi/Angelman region RNA 4 Homo sapiens
6 The resected tumors from the eight HCQ-treated patients with elevated plasma Par-4 levels, but not the resected tumor from the patient who failed to induce plasma Par-4 levels, exhibited TUNEL-positivity indicative of apoptosis. Hydroxychloroquine Prader Willi/Angelman region RNA 4 Homo sapiens